Skip to main content
. Author manuscript; available in PMC: 2021 Aug 3.
Published in final edited form as: Eur Cell Mater. 2021 May 20;41:576–591. doi: 10.22203/eCM.v041a37

Fig. 1. LPS and TAK-242 treatment study design and outcome measures.

Fig. 1.

For part 2 studies, cells were tested under one of 4 treatment groups: (i) untreated, (ii) LPS, (iii) TAK-242, (iv) LPS + TAK-242. TAK-242 was introduced into the cell culture 1 h prior to 24 h co-treatment with LPS.